Background illustration for clinical trials search

Paid Clinical Trials Irving

Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Converting HR+ Breast Cancer Into an Individualized Vaccine

for
Breast Cancer
Location: Dallas TX, Houston TX, New York NY
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 18 - 70+

Code: NCT03804944

Phase 2, Recruiting

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

for
Small Cell Lung Cancer (SCLC ),
Location: Dallas TX, Houston TX, St Louis MO, Nashville TN,
Sponsor: Moonlight Bio, Inc

Sex: All

Age: 18+

Code: NCT07488923

Phase 1, Recruiting

A Polypill for Acute Coronary Syndrome

for
Acute Coronary Syndrome
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18+

Code: NCT07032389

Phase 2, Recruiting

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

for
Carcinoma, Renal Cell
Location: Dallas TX, Germantown TN, St Louis MO, Marietta GA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07489495

Phase 3, Recruiting

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

for
Recurrent World Health Organization (WHO) Grade II Glioma,
Location: Dallas TX, St Louis MO, Birmingham AL, Indianapolis IN,
Sponsor: University of California, San Francisco

Sex: All

Age: 1 - 25

Code: NCT04485559

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

for
Ovarian Cancer
Location: Dallas TX, Fort Worth TX, Tyler TX, Abilene TX,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT07059845

Phase 2, Recruiting

Zenith® Fenestrated+ Clinical Study

for
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm,
Location: Dallas TX, Houston TX, St Louis MO, Birmingham AL,
Sponsor: Cook Research Incorporated

Sex: All

Age: 18+

Code: NCT04875429

Recruiting

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease

for
Metastatic Breast Cancer in the Liver
Location: Dallas TX, Columbus OH, Tampa FL, Cleveland OH,
Sponsor: Delcath Systems Inc.

Sex: All

Age: 18+

Code: NCT06875128

Phase 2, Recruiting

DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma

for
Refractory Melanoma
Location: Dallas TX, Birmingham AL, Gilbert AZ, Scottsdale AZ,
Sponsor: Diakonos Oncology Corporation

Sex: All

Age: 18+

Code: NCT07288112

Phase 1, Phase 2, Recruiting

Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial

for
Alcohol-associated Hepatitis
Location: Dallas TX, Louisville KY, Indianapolis IN, Rochester MN,
Sponsor: Samer Gawrieh

Sex: All

Age: 18 - 70

Code: NCT07060638

Phase 2, Recruiting

Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma

for
Low Grade Upper Tract Urothelial Carcinoma
Location: Dallas TX, Austin TX, Houston TX, St Louis MO,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT07265947

Phase 2, Recruiting

An International Observational Study of Adults With Acute Infection

for
Infectious Disease
Location: Dallas TX, Houston TX, Kansas City KS, Omaha NE,
Sponsor: University of Minnesota

Sex: All

Age: 18+

Code: NCT07069400

Recruiting

A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)

for
Pompe Disease (Late-onset), Pompe Disease Late-Onset, LOPD
Location: Dallas TX, Durham NC, Pittsburgh PA, Irvine CA,
Sponsor: AskBio Inc

Sex: All

Age: 18 - 65

Code: NCT07282847

Phase 1, Phase 2, Recruiting

The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

for
Hemorrhagic Stroke, Aneurysm, Intracranial, Saccular Aneurysm,
Location: Dallas TX, Oklahoma City OK, Jacksonville FL,
Sponsor: phenox Inc.

Sex: All

Age: 18+

Code: NCT07143019

Recruiting

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

for
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukaemia,
Location: Dallas TX, Salt Lake City UT
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 0+

Code: NCT06357754

Recruiting

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

for
Neuroblastoma
Location: Dallas TX, Fort Worth TX, Memphis TN, Aurora CO,
Sponsor: New Approaches to Neuroblastoma Therapy Consortium

Sex: All

Age: 1 - 31

Code: NCT06450041

Phase 2, Recruiting

Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder

for
GRIN-related Neurodevelopmental Disorder
Location: Dallas TX, Austin TX, Houston TX, Aurora CO,
Sponsor: GRIN Therapeutics, Inc.

Sex: All

Age: 0 - 18

Code: NCT07224581

Phase 3, Recruiting

Continued Pressure for Alveolar Protection (CPAP Trial)

for
Bronchopulmonary Dysplasia (BPD)
Location: Dallas TX, Houston TX, Jackson MS, Albuquerque NM,
Sponsor: NICHD Neonatal Research Network

Sex: All

Age: 0

Code: NCT07417111

Recruiting

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

for
Plaque Psoriasis
Location: Dallas TX, Arlington TX, Oklahoma City OK, Cypress TX,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 40+

Code: NCT07116967

Phase 3, Recruiting

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Dallas TX, Denison TX, San Antonio TX, Kansas City MO,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06997497

Phase 3, Recruiting